Altria Dividend Yield, Growth Outlook and Valuation

The appeal is grounded in Altria’s ability to defend earnings in a declining category. Smoking rates in the U.S. have fallen for decades, but the company has offset that structural decline by raising cigarette prices, cutting costs and buying back shares. It is also trying to build a smoke-free business around e-cigarettes, nicotine pouches and other products, with a goal of generating at least $5 billion in smoke-free revenue by 2028. Analysts expect earnings per share to grow at a 13% compound annual rate from 2025 to 2028 even as revenue rises only modestly, a sign that the story is less about top-line expansion than about disciplined cash extraction.

That is why the stock continues to screen as a defensive income play rather than a growth name. Altria spent about 78% of free cash flow on dividends over the past year, which suggests room for further increases as long as the core business remains stable. At roughly 13 times forward earnings, it also trades at a discount to the broader market, which helps explain why yield-focused investors keep circling the stock despite the long-term decline in smoking prevalence.

The risk case is straightforward: Altria’s dividend is only as secure as its pricing power and its ability to transition beyond cigarettes. If smoke-free products fail to scale fast enough, or if regulation and competition pressure margins, the company would have less flexibility to keep lifting payouts at the same pace. But for now, the investment thesis remains clear: in a market where many high-yield stocks rely on cyclical profits or leveraged balance sheets, Altria’s combination of long dividend history, steady cash flow and moderate valuation still makes it one of the clearest income compounds on the board.